Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Kidney Failure, Chronic × hematide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Classical hematology 1

Conditions

Anemia 2 Renal Insufficiency, Chronic 1 Neoplasms 1 Kidney Failure, Chronic 1

Interventions

Kidney Transplantation 2 peginesatide 1 hematide 1 carfilzomib 1 belantamab mafodotin 1 Sitagliptin Phosphate 1 Duration of Therapy 1 Cyclosporine 1 Cyclophosphamide 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00097747 2012-12-21

Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

Affymax

Phase 1 Completed

Classical hematologyGenitourinary

Anemia, Kidney Failure, Chronic, Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡